Cite
MLA Citation
Rocío García‐Carbonero et al.. “Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First‐Line Metastatic Colorectal Cancer.” Oncologist, vol. 22, 2017, p. 1281. http://access.bl.uk/ark:/81055/vdc_100054383523.0x000023